How cannabis use affects alcohol treatment outcomes in adolescents
Effects of cannabis use on community-based alcohol treatment outcomes in adolescents
This study is looking at how using cannabis affects teenagers who are getting help for alcohol problems and other mental health issues, and it wants to hear their thoughts on cannabis while they’re in treatment to find better ways to support them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-11054894 on NIH RePORTER |
What this research studies
This research investigates the impact of cannabis use on adolescents undergoing treatment for alcohol use disorder (AUD) and co-occurring psychiatric disorders. It aims to understand how cannabis influences treatment processes and outcomes in real-world community settings. The study will involve qualitative interviews with adolescents to gather their perspectives on cannabis use during treatment, as well as quantitative assessments to analyze treatment outcomes. By focusing on adolescents in community-based programs, the research seeks to identify effective intervention strategies tailored to this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents under 21 years old who are in treatment for alcohol use disorder and also use cannabis.
Not a fit: Patients who do not use cannabis or are not undergoing treatment for alcohol use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for adolescents with alcohol use disorder and co-occurring conditions, enhancing their recovery outcomes.
How similar studies have performed: While there is existing research on cannabis use in adult alcohol treatment, this specific focus on adolescents is relatively novel and untested.
Where this research is happening
Columbia, United States
- University of Missouri-Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Wycoff, Andrea M. — University of Missouri-Columbia
- Study coordinator: Wycoff, Andrea M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.